Clinical trials recruiting in Almaty, Kazakhstan
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 2Not applicable 7
Conditions recruiting in Almaty, Kazakhstan
Recruiting trials in Almaty, Kazakhstan
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
- Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
- Expanding Medication-Assisted Therapies in Central Asia
- INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Prospective Urban Rural Epidemiology Study
- TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric Bypass
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Common questions
How many clinical trials are recruiting in Almaty, Kazakhstan?
10 recruiting trials have at least one study site in Almaty, Kazakhstan.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.